These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16111450)

  • 1. Psychiatric symptoms associated with ephedra use.
    Maglione M; Miotto K; Iguchi M; Hilton L; Shekelle P
    Expert Opin Drug Saf; 2005 Sep; 4(5):879-84. PubMed ID: 16111450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
    Maglione M; Miotto K; Iguchi M; Jungvig L; Morton SC; Shekelle PG
    Am J Psychiatry; 2005 Jan; 162(1):189-91. PubMed ID: 15625222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
    Shekelle PG; Hardy ML; Morton SC; Maglione M; Mojica WA; Suttorp MJ; Rhodes SL; Jungvig L; Gagné J
    JAMA; 2003 Mar; 289(12):1537-45. PubMed ID: 12672771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA v. ephedra: is it time to lift the ban?
    Pyle KR
    Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
    [No Abstract]   [Full Text] [Related]  

  • 5. Ocular side effects from herbal medicines and nutritional supplements.
    Fraunfelder FW
    Am J Ophthalmol; 2004 Oct; 138(4):639-47. PubMed ID: 15488795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural-born killers.
    Mandavilli A
    Nat Med; 2003 Jun; 9(6):634-5. PubMed ID: 12778149
    [No Abstract]   [Full Text] [Related]  

  • 7. Ephedra-associated cardiomyopathy.
    Naik SD; Freudenberger RS
    Ann Pharmacother; 2004 Mar; 38(3):400-3. PubMed ID: 14742827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotretinoin and the controversy of psychiatric adverse effects.
    Strahan JE; Raimer S
    Int J Dermatol; 2006 Jul; 45(7):789-99. PubMed ID: 16863513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement.
    Sultan S; Spector J; Mitchell RM
    Mayo Clin Proc; 2006 Dec; 81(12):1630-1. PubMed ID: 17165643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health risks raised by ephedra in food supplements].
    van Riel AJ; de Vries I; Meulenbelt J
    Ned Tijdschr Geneeskd; 2003 Oct; 147(41):2017-9. PubMed ID: 14587144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pilot study for the surveillance of adverse reactions to herbal preparations and dietary supplements].
    Menniti-Ippolito F; Mazzanti G; Firenzuoli F; Bianchi A; Raschetti R
    Ann Ist Super Sanita; 2005; 41(1):39-42. PubMed ID: 16037648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No pain, no gain--exercise-induced rhabdomyolysis associated with the performance enhancer herbal supplement ephedra.
    Stahl CE; Borlongan CV; Szerlip M; Szerlip H
    Med Sci Monit; 2006 Sep; 12(9):CS81-4. PubMed ID: 16940935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbal weight-loss supplement misadventures per a regional poison center.
    Robinson RF; Griffith JR; Nahata MC; Mahan JD; Casavant MJ
    Ann Pharmacother; 2004 May; 38(5):787-90. PubMed ID: 15044657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of ephedra: lessons learned.
    Soni MG; Carabin IG; Griffiths JC; Burdock GA
    Toxicol Lett; 2004 Apr; 150(1):97-110. PubMed ID: 15068827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
    Nykamp DL; Fackih MN; Compton AL
    Ann Pharmacother; 2004 May; 38(5):812-6. PubMed ID: 15026566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of herbal supplements: a guide for cardiologists.
    Cohen PA; Ernst E
    Cardiovasc Ther; 2010 Aug; 28(4):246-53. PubMed ID: 20633025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing the potential risks associated with ephedra use: a review of recent efforts.
    Schulman S
    Public Health Rep; 2003; 118(6):487-92. PubMed ID: 14563905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to ban ephedra--now.
    Guharoy R; Noviasky JA
    Am J Health Syst Pharm; 2003 Aug; 60(15):1580-2. PubMed ID: 12951759
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety assurances for dietary supplements policy issues and new research paradigms.
    Basch EM; Servoss JC; Tedrow UB
    J Herb Pharmacother; 2005; 5(1):3-15. PubMed ID: 16093231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ephedrine and ephedra in weight loss products and other preparations].
    van der Hooft CS; Stricker BH
    Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.